CKD-382
/ Chong Kun Dang
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
November 04, 2021
A Study to Evaluate the PK, PD and Safety of CKD-382 in Healthy Subjects
(clinicaltrials.gov)
- P1; N=42; Recruiting; Sponsor: Chong Kun Dang Pharmaceutical
Clinical • New P1 trial • Gastroesophageal Reflux Disease
January 11, 2021
A Study to Compare PK, PD and Safety of CKD-382 in Healthy Subjects
(clinicaltrials.gov)
- P1; N=48; Recruiting; Sponsor: Chong Kun Dang Pharmaceutical
Clinical • New P1 trial • Gastroesophageal Reflux Disease
1 to 2
Of
2
Go to page
1